Stocks
Fate Therapeutics (FATE) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -31.3% | -58.2% | -43.7% | -58.4% | -65.8% | -72.3% | ||
| Changes by years, y/y, % | +14pp | -27pp | +15pp | -15pp | -7pp | +7.8% | |||
Fate Therapeutics. ROE, %
Fate Therapeutics. ROE, changes, pp
Fate Therapeutics (FATE) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -61.0% | -65.6% | -66.7% | -65.8% | -72.3% | -72.3% | |
| Changes by years, y/y, % | -16pp | -21pp | -17pp | -7pp | -11pp | |||
| Changes by quarters, q/q, % | -3pp | -5pp | -1pp | +1pp | -6pp | |||
